Yufan Cheng
Fudan University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yufan Cheng.
Journal of Surgical Oncology | 2010
Xiaowen Liu; Yufan Cheng; Weiqi Sheng; Hongfen Lu; Yu Xu; Ziwen Long; Huiyan Zhu; Yanong Wang
There were no comprehensive studies on the clinicopathologic features and prognosis of alpha‐protein‐producing gastric cancer. The aim of this study was to elucidate the clinicopathologic characteristics and prognostic factors of alpha‐fetoprotein (AFP)‐producing gastric cancer.
The American Journal of Surgical Pathology | 2010
Xiaowen Liu; Yufan Cheng; Weiqi Sheng; Hongfen Lu; Xiaoli Xu; Yu Xu; Ziwen Long; Huiyan Zhu; Yanong Wang
ObjectiveTo investigate the different nature between hepatoid adenocarcinoma of the stomach (HAS) and common stomach cancer without the hepatoid differentiation areas (non-HAS). MethodsFrom January 1996 to December 2007, 45 patients were diagnosed as HAS on the basis of the characteristic histologic features resembling hepatocellular carcinoma in Fudan University Shanghai Cancer Center. The clinicopathologic features and the relevant prognosis of these patients were evaluated. In addition, 225 stage-matched common stomach cancer patients were selected as controls. ResultsHistologically, the polygonal tumor cells were arranged in trabecular fashion or solid nests separated by narrow fibrous stroma composed of sinusoid-like capillaries. Immunohistochemically, the tumor cells were positive for α-fetoprotein. Under transmission electron microscope, numerous circular granules of dense electron were found in the cytoplasm. HAS showed a higher rate of vascular invasion, lymph node metastasis, and liver metastasis than non-HAS. The 5-years survival rates of HAS and non-HAS were 9% and 44%, respectively. The prognosis of HAS was poorer than that of non-HAS (P<0.05). ConclusionHAS had different clinicopathologic features and prognosis from non-HAS.
Histopathology | 2017
Ruohong Shui; Yufan Cheng; Qianming Bai; Wentao Yang
Secretory breast carcinoma is a rare, low‐grade, translocation‐associated invasive carcinoma with unique morphology and excellent prognosis. Three patterns (microcystic, tubular, solid) have often been described in secretory carcinoma. Herein, we reported one case of secretory breast carcinoma with an uncommon papillary‐predominant growth pattern.
Histopathology | 2018
Xiaoli Xu; Rui Bi; Ruohong Shui; Baohua Yu; Yufan Cheng; Xiaoyu Tu; Wentao Yang
Pure mucinous carcinoma (PMC) of the breast is a low‐grade cancer. In this study, we aimed to elucidate the prognostic significance of micropapillary structures in breast PMC.
Diagnostic Pathology | 2017
Xiangjie Sun; Ke Zuo; Dan Huang; Baohua Yu; Yufan Cheng; Wentao Yang
BackgroundInvasive pleomorphic lobular carcinoma (PLC) is an aggressive subtype of invasive lobular carcinoma of the breast, which has its own histopathological and biological features. The metastatic patterns for PLC are distinct from those of invasive ductal carcinoma. In addition, pancreatic metastasis from PLC is extremely rare.Case presentationWe report a rare case of a 48-year-old woman presenting with clinical gastrointestinal symptoms and pancreatic metastasis of PLC. The pancreatic tumor was composed of pleomorphic tumor cells arranged in the form of solid sheets and nests and as single files, with frequent mitotic figures, nucleolar prominence, high nuclear to cytoplasmic ratio and loss of cohesion. The malignant cells were positive for p120 (cytoplasmic) and GATA3 and negative for estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, E-cadherin, gross cystic disease fluid protein 15 and mammaglobin, which indicated a lobular carcinoma phenotype of the breast.ConclusionsTo the best of our knowledge, this is one of the few reported cases in the literature of pancreatic metastasis of invasive lobular carcinoma of the breast, of which the definitive diagnosis was obtained only after surgery. Rare metastasis sites should be considered, particularly, when a patient has a medical history of PLC.
International Journal of Clinical and Experimental Pathology | 2014
Fangfang Zhong; Rui Bi; Baohua Yu; Yufan Cheng; Xiaoli Xu; Ruohong Shui; Wentao Yang
Diagnostic Pathology | 2016
Rui Bi; Xuxia Shen; Weiwei Zhang; Yufan Cheng; Zheng Feng; Xu Cai; Wentao Yang
Chinese journal of pathology | 2014
Rui Bi; Yufan Cheng; Baohua Yu; Ruohong Shui; Wentao Yang; Xiaoli Xu
Chinese journal of pathology | 2014
Shuling Zhou; Baohua Yu; Yufan Cheng; Xiaoli Xu; Ruohong Shui; Rui Bi; Hongfen Lu; Xiaoyu Tu; Wentao Yang
Chinese journal of pathology | 2016
Chang B; Lu Lx; Xiaoyu Tu; Yufan Cheng; Rui Bi; Wen Tao Yang